DK3370756T3 - Kombination af canrenoat og exenatid - Google Patents

Kombination af canrenoat og exenatid Download PDF

Info

Publication number
DK3370756T3
DK3370756T3 DK16802132.7T DK16802132T DK3370756T3 DK 3370756 T3 DK3370756 T3 DK 3370756T3 DK 16802132 T DK16802132 T DK 16802132T DK 3370756 T3 DK3370756 T3 DK 3370756T3
Authority
DK
Denmark
Prior art keywords
exenatid
canrenoat
combination
Prior art date
Application number
DK16802132.7T
Other languages
English (en)
Inventor
George Vogiatzis
Original Assignee
Genesis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Pharma Sa filed Critical Genesis Pharma Sa
Application granted granted Critical
Publication of DK3370756T3 publication Critical patent/DK3370756T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
DK16802132.7T 2015-11-06 2016-11-04 Kombination af canrenoat og exenatid DK3370756T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20150100486 2015-11-06
PCT/IB2016/001582 WO2017077378A1 (en) 2015-11-06 2016-11-04 Combination

Publications (1)

Publication Number Publication Date
DK3370756T3 true DK3370756T3 (da) 2020-06-02

Family

ID=57421900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16802132.7T DK3370756T3 (da) 2015-11-06 2016-11-04 Kombination af canrenoat og exenatid

Country Status (16)

Country Link
US (2) US10172914B2 (da)
EP (1) EP3370756B1 (da)
JP (1) JP6928611B2 (da)
CN (1) CN108472333B (da)
CY (1) CY1123041T1 (da)
DK (1) DK3370756T3 (da)
ES (1) ES2791301T3 (da)
HR (1) HRP20200845T1 (da)
HU (1) HUE049732T2 (da)
LT (1) LT3370756T (da)
ME (1) ME03734B (da)
PL (1) PL3370756T3 (da)
PT (1) PT3370756T (da)
RS (1) RS60354B1 (da)
SI (1) SI3370756T1 (da)
WO (1) WO2017077378A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114423461A (zh) * 2019-07-09 2022-04-29 杰尼西斯制药有限公司 组合
CN118284417A (zh) 2021-08-27 2024-07-02 杰尼西斯制药有限公司 Nurr1激动剂与醛固酮拮抗剂、胰岛素调节剂和磺酰脲中的至少一种的组合

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US20040214804A1 (en) * 2003-04-25 2004-10-28 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-obesity agent
WO2007050485A2 (en) * 2005-10-25 2007-05-03 Merck & Co., Inc. Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension
NZ594044A (en) * 2009-02-13 2014-08-29 Boehringer Ingelheim Int Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
CN101810859A (zh) * 2010-02-09 2010-08-25 王丽燕 包含苯胺衍生物的药物组合物
EP2768856A4 (en) 2011-10-18 2015-05-27 Prolynx Llc PEG CONJUGATES OF EXENATIDE
CN103087139B (zh) * 2011-11-08 2016-08-03 中国科学院上海药物研究所 一种坎利酮衍生物类甾体化合物、其制备方法及其在制备依普利酮中的用途

Also Published As

Publication number Publication date
CN108472333B (zh) 2023-05-12
SI3370756T1 (sl) 2020-08-31
LT3370756T (lt) 2020-07-10
ES2791301T3 (es) 2020-11-03
ME03734B (me) 2021-01-20
JP2018537522A (ja) 2018-12-20
CN108472333A (zh) 2018-08-31
PT3370756T (pt) 2020-05-18
CY1123041T1 (el) 2021-10-29
WO2017077378A1 (en) 2017-05-11
HUE049732T2 (hu) 2020-10-28
US20190290721A1 (en) 2019-09-26
US10172914B2 (en) 2019-01-08
HRP20200845T1 (hr) 2020-08-07
EP3370756B1 (en) 2020-04-08
EP3370756A1 (en) 2018-09-12
PL3370756T3 (pl) 2020-10-19
JP6928611B2 (ja) 2021-09-01
US20170333519A1 (en) 2017-11-23
RS60354B1 (sr) 2020-07-31

Similar Documents

Publication Publication Date Title
DK3283107T3 (da) Sammensætninger omfattende en kombination af ipilimumab og nivolumab
DK3289168T3 (da) Forsegling og aktivering af borehul
DK3259253T3 (da) Sulfonylureaer og relaterede forbindelser og brug af samme
DK3368534T3 (da) Valbenazin-ditosylat og polymorfer deraf
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3380101T3 (da) Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3288553T3 (da) Kombinationer af cannabinoider og n-acylethanolaminer
DK3134530T3 (da) Behandling af hyperbilirubinæmi
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3350201T3 (da) Manipulerede fytaser og fremgangsmåder til anvendelse af samme
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3102555T3 (da) Sammensætninger af forbindelser og anvendelser deraf
DK3364958T3 (da) Modulatorer af sestrin-gator2-interaktion og anvendelser deraf
DK3394065T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf
DK3099800T3 (da) Ekspression og oprensning af crm197 og beslægtede proteiner
DK3280839T3 (da) Indretning til fremføring og spredning af stofstykker
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3307267T3 (da) Behandling af multipel sklerose
DK3178324T3 (da) Mikrobicid og fremgangsmåde til fremstilling af samme
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
DK3319609T3 (da) Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer
DK3265126T3 (da) Kombinationsformulering af tesofensin og metoprolol